1. A Pooled Safety Analysis from the Ustekinumab Crohn's Disease and Psoriatic Diseases Phase 2 and 3 Clinical Trial Programs: 2016 ACG Presidential Poster Award: 662. (October 2016) Authors: Sands, Bruce; Ghosh, Subrata; DeVilliers, Willem; Ott, Elyssa; Gasink, Chris; Lang, Yinghua; Szapary, Philippe; Jacobstein, Doug; Feagan, Brian Journal: American journal of gastroenterology Issue: Volume 111(2016)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Efficacy and Safety of Dose Adjustment and Delayed Response to Ustekinumab in Moderate ‐ Severe Crohn's Disease Patients: Results from the IM‐UNITI Maintenance Study: 2016 ACG Presidential Poster Award: 663. (October 2016) Authors: Sands, Bruce; Gasink, Chris; Jacobstein, Doug; Gao, Long Long; Johanns, Jewel; Szapary, Philippe; Colombel, Jean‐Frederic; Targan, Stephan; Ghosh, Subrata; Sandborn, William J. Journal: American journal of gastroenterology Issue: Volume 111(2016)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Endoscopic Healing in Induction and Maintenance with Ustekinumab in the Phase 3 UNITI Crohn's Disease Program: 2016 ACG Presidential Poster Award: 605. (October 2016) Authors: Sandborn, William J.; Gasink, Chris; Chan, Daphne; Lang, Yinghua; Pollack, Paul; Hanauer, Stephen; Wolf, Douglas; Jacobstein, Doug; Johanns, Jewel; Szapary, Philippe; Feagan, Brian; Rutgeerts, Paul Journal: American journal of gastroenterology Issue: Volume 111(2016)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗